Gene test: does sitagliptin work better in some people?
NCT ID NCT04323189
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times
Summary
This study looks at how the diabetes drug sitagliptin affects people who naturally have lower levels of a protein called DPP4 due to their genes. Researchers want to see if these individuals have better blood sugar control and higher levels of certain helpful substances compared to when they take a placebo. The study involves 20 adults from a biobank and aims to understand how genetics influence drug response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.